AZD6482 KIN-193 cas 1173900-33-8
| Product name:AZD6482 KIN-193 | Purity:98% min |
| CAS NO:1173900-33-8 | Solubility:DMSO : ≥ 100 mg/mL (244.83 mM) |
| Molecular Formula:C22H24N4O4 | Package:Package according to customer requirements |
| Molecular Weight:408.45 | Storage:Store at -20℃ |
AZD6482 is a potent, selective and ATP competitive PI3Kβ inhibitor (IC(50) 0.01 μm). AZD6482 inhibited insulin-induced human adipocyte glucose uptake in vitro (IC(50) of 4.4 μm). This is the first human target validation for PI3Kβ inhibition as anti-platelet therapy showing a mild and generalized antiplatelet effect attenuating but not completely inhibiting multiple signaling pathways with an impressive separation towards primary hemostasis. AZD6482 at 'supratherapeutic' plasma concentrations may attenuate insulin signaling, most likely through PI3Kα inhibition.
Related Products:
PKI-402; Voxtalisib; Pilaralisib; PI-3065; VS-5584; PIK-294; GSK1059615; AZD8186; CUDC-907; AZD8835; AMG319; Buparlisib hydrochloride; Umbralisib; PIK-III; VPS34-IN1; VPS34 inhibitor 1; Wortmannin
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.